AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

661.778

-8.321-1.24%

Number of Gainers:12

Number of Losers:10

Number of Flat:21

PE:- -

High:671.674

Open:671.234

Low:660.092

Close:670.099

Volume:76.53M

Turnover:276.05M

Market Cap:94.42B

Float Cap:91.19B

Loading ...

Inhibitor Therapeutics Held Annual Shareholder Meeting, Elected Directors

PDI Gold And 2 Australian Founder Led Growth Stocks

Simply Wall St.

CSL Acknowledges Shareholder Frustration, Says Company Was Slow in Adapting to Competitive Pressures

MT Newswires Live

Polynovo Limited-Dean Phizacklea and Andrew Price Appointed to Pnv Board

THOMSON REUTERS

US Closing Bell | Stocks retreat as tech-led selloff drags Nasdaq 0.8%

US Closing Bell

Australian Shares Fall; White Cliff Says Hancock Prospecting to Take 13.5% Stake With Nearly AU$9 Million Investment

MT Newswires Live

Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says

MT Newswires Live

Immutep Gets a New Bull at Jefferies

Paradigm Biopharmaceuticals Names Chief Medical Officer

MT Newswires Live

Mayne Pharma Signs Five-Year Exclusive Deal With Italfarmaco

MT Newswires Live

Mayne Pharma Group Ltd-Myx Signs Licence Agreement for Blissel in Australia

THOMSON REUTERS

Mayne Pharma Group - Signs Exclusive Five-Year Licence Agreement with Italfarmaco S.a for Blissel in Australia

THOMSON REUTERS

Paradigm Biopharmaceuticals Ltd-DR Daniel Furtner Appointed Chief Medical Officer

THOMSON REUTERS

Prescient Therapeutics Ltd-Prescient Therapeutics - Extension of Share Purchase Plan

THOMSON REUTERS

Australia's Dimerix Rises on Patent Approval in Mexico

ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles

MT Newswires Live

Biotron - Michelle Miller Steps Down as Managing Director and CEO

THOMSON REUTERS

Biotron - Board Commences Search for New Leadership Effective Immediately

THOMSON REUTERS

Biotron Ltd-Resignation of Managing Director and Appendix 3Z

THOMSON REUTERS

CitiFirst CSL Instalments Dividend Final Amount-CTW

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":661.7781,"timestamp":1789711199746,"preClose":670.09937,"halted":0,"volume":76528923,"delay":0,"changeRate":-0.012418,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-8.321289,"latestTime":"09-18 16:00:00 AEST","open":671.2342,"high":671.67377,"low":660.09204,"amount":276050292.45,"amplitude":0.017284,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789948800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789689600000,1789711200000]],"turnoverRate":0.003001,"increases":15,"decrements":9,"flats":19,"marketCap":94421634415.75,"floatMarketCap":91190879063.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":671.67377,"amplitude":0.017284,"preClose":670.09937,"low":660.09204,"latestPrice":661.7781,"volume":76528923,"delay":0,"open":671.2342,"prevYearClose":644.3692,"prevWeekClose":634.95,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":634.95,"twentyDayClose":653.313,"sixtyDayClose":459.325,"secType":"PLATE","market":"AU","turnoverRate":0.003001,"marketCap":94421634415.75,"floatMarketCap":91190879063.625,"timestamp":1789711199746,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":12,"down":10,"flat":21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668978711","title":"Inhibitor Therapeutics Held Annual Shareholder Meeting, Elected Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2668978711","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668978711?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:01","pubTimestamp":1789761667,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics held annual shareholder meeting, elected directorsInhibitor Therapeutics held its annual stockholders meeting on Sept. 15, 2026.Stockholders selected six directors for one-year ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL1klb8j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTI","BK7508","BK7096","BK4139","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668888661","title":"PDI Gold And 2 Australian Founder Led Growth Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2668888661","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668888661?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:29","pubTimestamp":1789748965,"startTime":"0","endTime":"0","summary":"Central banks are lifting interest rates again, and history shows that higher borrowing costs often hit fast growers hardest. Australian companies where founders and executives hold big stakes can sometimes weather that pressure better, because management feels every share price move in their own net worth. This article looks at three fast growing, high insider ownership stocks from our screener and explains why each might deserve a spot on your watchlist.\nThe three stocks below are just a...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/pdi-gold-and-2-australian-founder-led-growth-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/pdi-gold-and-2-australian-founder-led-growth-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","BK7067","XJO.AU","MSB.AU","IMLC.AU","PDI.AU","GEAR.AU","TLX.AU","XAO.AU","VAS.AU","BK7508","XKO.AU","IOZ.AU","GIVE.AU","QFN.AU","OZR.AU","OZF.AU","BK4139","E200.AU","BEAR.AU","ZYAU.AU","BK7501","STW.AU","IISV.AU","VAP.AU","BBOZ.AU","EIGA.AU","DACE.AU","TLX","SLF.AU","USD","USD.AU","QRE.AU","IIGF.AU","PDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668251934","title":"CSL Acknowledges Shareholder Frustration, Says Company Was Slow in Adapting to Competitive Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2668251934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668251934?lang=en_us&edition=fundamental","pubTime":"2026-09-17 08:34","pubTimestamp":1789605262,"startTime":"0","endTime":"0","summary":"CSL's  board acknowledged shareholder frustration over the company's \"disappointing\" commercial and financial performance, saying it aims to win back their trust by delivering results, according to a Thursday filing with the Australian bourse.The company pointed to a multibillion-dollar statutory loss driven by restructuring, a pending leadership transition, and the recognition of substantial non-cash balance sheet impairments as issues that have vexed shareholders.\"We built up substantial fixed costs, we were slow to adapt to competitive pressures, our research and development efforts didn't deliver and some investments the company made did not perform,\" the biotechnology company said in a notice for its annual general meeting scheduled for Oct. 27.CSL leadership is \"acting with urgency\" to address these issues through a strategy to invest in the core of its plasma business, with only selective investment beyond that area.\"We must adapt more rapidly as markets evolve and ensure our in","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7501","BK7508","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668693985","title":"Polynovo Limited-Dean Phizacklea and Andrew Price Appointed to Pnv Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2668693985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668693985?lang=en_us&edition=fundamental","pubTime":"2026-09-17 06:23","pubTimestamp":1789597397,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUE77J5M1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PNV.AU","BK7126","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187624168","title":"US Closing Bell | Stocks retreat as tech-led selloff drags Nasdaq 0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187624168","media":"US Closing Bell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187624168?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:03","pubTimestamp":1789502607,"startTime":"0","endTime":"0","summary":"MarketSeptember 16, U.S. stocks closed lower across the board amid renewed rate-hike anxiety and profit-taking in mega-cap technology names. The Dow Jones Industrial Average fell 0.63%, the S&P 500...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c1e522724dcc46c8aa3a2b2d1530b6c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983260115.SGD","ESLG","LU2083900584.USD","HK0000304805.HKD","LU0347712357.USD","LU1861215975.USD","SG9999001424.SGD","ANV","BK4598","IE00BQXX3F31.USD","LU1261432733.SGD","BK4571","LU0289961442.SGD","THMR","LU1032955483.USD","LU2125154935.USD","LU2210149790.SGD","LU1712237335.SGD","LU0466842654.USD","ORCX","BK4535","LU0203201768.USD","LU0215105999.USD","BK4575","BK4592","LU1221951046.USD","IE0005OL40V9.USD","IE000SO60NU8.SGD","LU2125909247.SGD","LU1489326972.SGD","SOXX","LU0265550946.USD","LU2237443465.HKD","LU1989773731.SGD","LU0109391861.USD","AAPB","LU2237443622.USD","IE00BKPKM429.USD","LU0683600562.USD","SG9999018865.SGD","LU0127658192.USD","AVL","LU2471134796.USD","LU0788109477.HKD","COIO","LU0158827948.USD","LU2023251221.USD","COII","MSFT","LU2294711713.HKD","LU0096364046.USD","LU1267930730.SGD","LU2065170008.USD","LU2092937148.SGD","LU1206713676.USD","LU2357627491.SGD","LU1496350171.SGD","AAPW","LU0070217475.USD","IE0009G5SDU7.USD","LU0871640123.AUD","LU2133065610.SGD","NVYY","LU1670711123.USD","NVD2.UK","LU0795875086.SGD","LU2506951958.HKD","LU2756315664.SGD","LU0068578508.USD","LU0894485498.HKD","HK0000914660.USD","AIPI","BK4605","LU2361044865.SGD","LU0494093205.USD","MSFL","SMH","LU0985320562.USD","BK4539","LU0225283273.USD","CNEQ","LU0133085943.USD","IE00B3S45H60.SGD","NVDB","CONI","BK4504","LU0210536198.USD","SG9999015341.SGD","IE00BDGV0183.EUR","LU2065171402.SGD","LU1548497426.USD","LU2360107168.USD","WNTR","FXL","LU0187121727.USD","BK4559","LU0784385840.USD","LU0689472784.USD","LU1334329650.SGD","LU1633808545.USD","LU2462591350.SGD","LU0823417737.USD","ICOI","AMDD","AMYY","LU2458330243.SGD","07711","LU0345768153.USD","ORAC","LU2462591277.SGD","LU2552382132.HKD","SG9999014575.USD","IE00BYXW3230.USD","LU1868837300.USD","LU0545562505.USD","TTXU","LU1670710661.SGD","LU0308772762.SGD","SGOOGmain","AVGX","BK4550","LU1697837992.HKD","LU1821325948.USD","NVDX","IE00B19Z9505.USD","LU0912757837.SGD","LU1642822529.SGD","LU1935042991.SGD","LU2506952097.USD","LU0472753341.HKD","LU2362541513.USD","LU2247934214.USD","IE00BK4W5M84.HKD","LU0994945656.USD","BK4538","IE00BN29S564.USD","MSTC","LU0823414478.USD","COIW","LU0787776722.HKD","LU1267930813.SGD","LU2347655073.USD","LU1699723380.USD","LU2089284900.SGD","TEK","SGXZ51526630.SGD","LU1582987597.SGD","GOOG","SG9999002224.SGD","AVGW","LU0208291251.USD","LU0198837287.USD","LU0957808578.USD","LU1670628061.USD","LU1582987324.SGD","SG9999015978.USD","BK4526","LU0353189763.USD","LU0444971666.USD","LU2322448957.HKD","LU1732800096.USD","09388","IE00BGHQDM52.EUR","LU0345774391.USD","MSTZ","ORCL","NVDS.UK","XLC","BK4204","LU0957791311.USD","FIAT","BK4006","LU2430703095.HKD","LU2125909916.SGD","LU2896262040.SGD","LU1429558221.USD","LU0251132253.USD","LU2505996509.AUD","LU1564329628.SGD","LU2286300806.USD","LU2461242641.AUD","LU2505996681.GBP","CAN.AU","3SMI.UK","IE00B19Z3B42.SGD","BK4510","IE00BQXX3D17.EUR","LU0511384066.AUD","LU0960925559.SGD","LU0433182093.SGD","BK4096","LU1989771016.USD","IE00BKDWB100.SGD","LU2063271972.USD","AIQ","LU0390134368.USD","OWNB","SNVD.UK","IE00BDCRKT87.USD","SGXZ31699556.SGD","AMDL","LU2097344357.USD","MTYY","SG9999001440.SGD","ESUM","LU1645745479.HKD","LU0266013472.USD","BK4573","LU0211331839.USD","LU0265550359.USD","LU0345768740.USD","LU1228905540.USD","LU0069063385.USD","LU0234570918.USD","LU1242518931.SGD","LU1032466523.USD","LU0354030511.USD","LU2095319765.USD","NVDA","IE00BZ199S13.USD","IE00BWXC8680.SGD","IE00BMPRXR70.SGD","SNVDAmain","LU0082616367.USD","LU1221951129.SGD","CNAV","LU0211328371.USD","LU1917777945.USD","LU2089985449.USD","LU2430703178.SGD","SMI3.UK","AMDU","SOXQ","NVD3.UK","LU1303367103.USD","LU2931357623.SGD","CONL","LU0323240290.USD","LU2463028550.USD","LU1861220207.SGD","BK4503","CHPX","2NVD.UK","LU1244550494.USD","IE00BK4W5L77.USD","BK4514","IE00BKVL7J92.USD","LU0708995401.HKD","LU1629891620.HKD","MSFD","HK0000819398.USD","MSFU","SAMD0main","LU1720051017.SGD","ABFL","LU0823421416.USD","TRUC","VGT","HK0000914686.HKD","LU0784385170.HKD","SMST","LU1127390331.HKD","LU1116320901.HKD","LU1564329032.USD","LU1989772840.SGD","MSFX","GTEK","LU0795875169.SGD","LU0823421333.USD","IE00B5TLWC47.USD","IE00BMPRXQ63.HKD","LU2271345857.HKD","IE00B4YYXB79.USD","HK0000304797.USD","IE000W1ABFV2.USD","LU0174119429.USD","LU2433249047.HKD","LU2092937221.SGD","BK4515","LU1169590202.USD","LU0348723411.USD","LU1868836757.USD","LU1935042488.USD","LU2764263203.CNY","LU2860962120.EUR","LU1815336760.USD","GXPC","LU0979878070.USD","LU1043141123.HKD","LU1144417596.USD","LU2244417387.USD","SG9999004303.SGD","IE00BJTD4V19.USD","LU1400636657.SGD","LU2100268510.USD","BK4023","LU2394011477.USD","AMUU","LU0528227936.USD","LU1564329461.SGD","LU0345774631.USD","SG9999001077.SGD","LU2764263039.SGD","IE00BZ9MQY76.HKD","LU0323591593.USD","LU2272731865.HKD","DAMD","LU0820561909.HKD","SMHX","NVII","LU0267386448.USD","MSFC","LU1868836591.USD","YQ","LU2506951875.HKD","METV","NVIW.SI","LU0316494557.USD","BAI","LU0868494708.USD","IE0004086264.USD","LU1935043536.SGD","CHPS","BK4532","LU1069344957.HKD","LU1880398554.USD","IE00BYQQ9H92.USD","LU2298321311.HKD","LU1244550577.SGD","AAPU","LU0557290698.USD","MSTY.UK","LU2746668974.SGD","LU2720916845.USD","LU2750360997.AUD","IE00B4JS1V06.HKD","HK0000306701.USD","MSII","APED","IE00BLSP4452.SGD","LU0312595415.SGD","LU1839511570.USD","LU2954938101.SGD","LU0965509101.SGD","BK4077","LU0757359368.USD","COIG","LU0077335932.USD","SG9999002232.USD","LEGR","LU0861579265.USD","LU1861220033.SGD","AVGC","LU2191332357.HKD","LU1880398471.USD","LU1935043452.HKD","LU0106261372.USD","LU1232071149.USD","07399","LU0395794307.EUR","LU0310799852.SGD","CLSE","LU0980610538.SGD","LU1670711040.USD","LU0889565833.HKD","SOXY","LU1979441026.SGD","QQQA","MVLL","LU0792757196.USD","CGDG","XNTK","LU0672654240.SGD","LU0061475181.USD","MRVL","LU0211327993.USD","COIA","07799","LU1301847155.USD","LU2750360641.GBP","FAI","LU2471134879.HKD","LU0149725797.USD","LU0061474960.USD","LU1003077747.HKD","LU1244550221.USD","LU2237443978.SGD","LU0011850046.USD","FTEC","IE00BJTD4N35.SGD","LU1674673428.USD","LU1914381329.SGD","LU2357305700.SGD","LU2487616109.SGD","PSI","TRFK","LU0234572021.USD","IE00B19Z8W00.USD","LU0109392836.USD","LU2237443382.USD","LU2265009873.SGD","HAKY","IE0000B7K699.USD","IE00B42XCP33.USD","CHAT","LU0965508806.USD","LU2250418816.HKD","LU2347655156.SGD","LU2360032135.SGD","NQmain","LU2456880835.USD","MSFY","LU0784384876.USD","09311","BK4501","IE00B5949003.HKD","LU0345769631.USD","SGXZ23171101.USD","LU1674673691.USD","LU2098885051.SGD","BK4566","LU2168564495.EUR","ARTY","SGXZ81514606.USD","LU1202635105.USD","LU1585245621.USD","IE00BDRTCR15.USD","LU1852331112.SGD","BK4608","AAPY","BK4549","LU0690374615.EUR","LU1084165304.USD","ORCS","LU2168564222.USD","LU0320765489.SGD","COIN","LU0072462426.USD","LU0081259029.USD","BK4587","LU0345770308.USD","LU2746668461.USD","IE00B19Z3581.USD","LU2087625088.SGD","LU2023250843.SGD","LU2999663052.SGD","CIBR","IE00BBT3K403.USD","SG9999014567.USD","COYY","AAPL","LU1280957306.USD","NVDY","MSFW","LU2452424414.USD","ILDR","LU1974910355.USD","LU0456855351.SGD","LU1861217088.USD","CAN","HK0000532082.HKD","LU0170899867.USD","IE00BVYPNV92.GBP","EFIV","IE000WAW04H5.SGD","GAMR","LU2756315318.SGD","LU0353189680.USD","LU1153585028.USD","FDIG","BK4516","LU2275660780.HKD","LU1989764748.USD","RETO","BK4123","IE00B19Z9P08.USD","LU1791710582.SGD","BK4614","COIX","BK4529","LU2242650005.HKD","BK4507","LU1992135399.USD","LU0784383803.USD","LU2491050071.SGD","LU0056508442.USD","LU0079474960.USD","LU2237443549.SGD","IE000BZT7R73.USD","IE000YTNTUN2.SGD","FTXL","TDIV","LU1037948541.HKD","AMDG","LU1066053197.SGD","LU1035773651.USD","LU1037948897.HKD","IE00B775H168.HKD","LU0345770993.USD","BK4533","MSTU","IE000M9KFDE8.USD","MST","LU2462157665.USD","IE0004091025.USD","IE0034235303.USD","IE00B1XK9C88.USD","LU1235294995.USD","LU1340139317.AUD","IE00BN8TJ469.HKD","LU1235295455.SGD","LU1989764664.SGD","LU0210528500.USD","SG9999014559.SGD","LU1988902786.USD","LU0823417653.USD","BLCK","LU2430703251.USD","LU0820561818.USD","SG9999015986.USD","LU2413666426.HKD","IE00BMPRXN33.USD","LU2279689827.SGD","CONX","IE00BFXG0V08.USD","LMI3.UK","LU2404859667.USD","LU0345769128.USD","IE00B3M56506.USD","LU2361044949.HKD","LU1923622614.USD","LU1169589451.USD","IE00BVYPNQ40.USD","LU2272731600.USD","BK4588","BK4596","LU2211815571.USD","LU2087621335.USD","BK7504","09799","LU0965509010.AUD","LU1623119135.USD","LU0097036916.USD","MSTY","LU2108987350.USD","BK4612","IE00BJLML261.HKD","LU2404859741.USD","LU2637965513.SGD","SORCLmain","LU2237957902.USD","LU1035775433.USD","LU0124676726.USD","VT","SMSFTmain","LU0949170772.SGD","LU2077746001.SGD","LU2125154778.USD","LU0154236417.USD","VOX","LU0070302665.USD","LU2322448791.USD","IE00B3SWFQ91.USD","LU0786609619.USD","LU1670756490.USD","LU0128525929.USD","LU0823414551.USD","BK4554","LU1732799900.SGD","IE00B1BXHZ80.USD","IE00BD6J9T35.USD","IE000ITXATA3.USD","LU0323239441.USD","3NVD.UK","LU0642271901.SGD","LU0964807845.USD","LU0823434740.USD","BK4543","LU2592432038.USD","LU1868837136.USD","LU1228905037.USD","LU2272731782.SGD","LU2543165471.USD","CONY","NVC","LU1564329115.USD","NVDW","LU2420271590.USD","BK4604","LU2471134523.USD","LU1059921491.USD","BK4581","LU2552382058.USD","AAPD","AMDC","LU2237443895.HKD","IE00BSNM7G36.USD","LU1236620834.HKD","LU0080751232.USD","LU0130102774.USD","BK4528","BK4574","3LMI.UK","LU1064131342.USD","LU1923623000.USD","LU2417539215.USD","LU1861127337.USD","LU0640476718.USD","LU2097344431.USD","USJW.SI","BK4567","USD","GB00B4LPDJ14.GBP","AMD","BK4527","SG9999011175.SGD","LU0203202063.USD","LU1551013342.USD","MSFO","IE0034235188.USD","LU1267930573.SGD","LU0943347566.SGD","LU0175139822.USD","LU0210533765.USD","BK7095","LU2089283258.USD","LU2168564065.EUR","CMAG","LU3102509885.SGD","LU2102340556.USD","AVGO","TYLG","GB00B4QBRK32.GBP","LU0107464264.USD","SG9999003800.SGD","LU0289739343.SGD","LU0719512351.SGD","LU2326559502.SGD","LU2023250504.SGD","LU0898699433.AUD","LU2290526834.HKD","LU1989772923.USD","LU2249611893.SGD","SG9999014542.SGD","IE00BFSS8Q28.SGD","LU1181866309.USD","LU2097829019.USD","LU1069347547.HKD","GB00BDT5M118.USD","LU2360107671.USD","IE00B7KXQ091.USD","LU2362541273.HKD","IETC","LU2491049909.HKD","07388","LU2065171311.SGD","LU1861558580.USD","NVDD","LU0690374961.EUR","SG9999015358.SGD","LU0289941410.SGD","LU1121112475.USD","LU0143551892.USD","LU0095938881.EUR","LU1989763005.USD","GOOP","BK4585","LU0314104364.USD","USXF","EPOW","BK4576","LU0061474705.USD","LU1506573853.SGD","LU0417517546.SGD","LU2168564149.EUR","BK4141","LU0048584097.USD","LU2413666699.HKD","LU1236620750.USD","LU2473716301.USD","LU0444973449.USD","LU1366192091.USD","LU1923622291.USD","LU1718418525.SGD","LU1116320737.USD","IOSX","LU1316542783.SGD","SG9999000418.SGD","IE00BHPRN162.USD","IE00BVYPNP33.GBP","IGV","LU0942090050.USD","NVD","LU1720051108.HKD","LU0738911758.USD","LU0072461881.USD","LU0256863902.USD","LU2360106780.USD","BK7502","CGBL","LU0724617625.USD","LU2552382215.SGD","LU0162691827.USD","GOOX","NULC","WISE","IE000F7OJYX1.SGD","SGXZ99366536.SGD","XLK","LU0868494617.USD","LU1934455863.HKD","BK4579","BK4525","HLP","LU0553294199.USD","LU0053666078.USD","LU1934455194.USD","BK4548","IE00BFSS7M15.SGD","BK4512","BK4097","LU0158827781.USD","LU1935042215.USD","LU2403377893.USD","MSTP","DAPP","IE00BYV24P56.USD","SG9999014880.SGD","LU0661504455.SGD","LU1691799644.USD","LU0648001328.SGD","LU2357125470.USD","BK4577","BK4553","IXN","LU0203347892.USD","LU0985489474.SGD","LU1435385759.SGD","LU1400636491.USD","LU2168563687.JPY","LU0289960550.SGD","LU0314106906.USD","LU1823568750.SGD","MSTW","LU1242518857.USD","AMDY","IE00BQXX3C00.GBP","LU2242649171.HKD","MRVU","HK0000320223.HKD","LU1951198990.SGD","AMDW","LU0708994859.HKD","AIS","LCLG","SPTE","LU1119994496.HKD","IE00BGHQF631.EUR","LU2361045086.USD","MACW.SI","LU0057025933.USD","IE000KEQY171.SGD","MSTR","LU2106854487.HKD","NVDL","LU1145028129.USD","LU1400636574.HKD","DTCR","LU0476273544.USD","IE00B19Z8X17.USD","MRVX","DIPS","IE000Q6AESB8.SGD","IE000MB6IJN5.SGD","BK4600","AVGG","LU1430594728.SGD","LU2237438978.USD","LU2506951792.HKD","AIFD","LU0342679015.USD","LU0882574139.USD","LU0820562030.AUD","LU2148611432.USD","LU0859254822.USD","LU1323610961.USD","ORCZ","LU0029864427.USD","SGXZ80539844.SGD","LU1188199696.SGD","LU0950375773.USD","LU0949170426.SGD","LU2111349929.HKD","APLY","IE00BJJMRY28.SGD","LU0238689110.USD","LU0006306889.USD","LTL","AVS","LU0302445910.USD","LU0965509283.SGD","LU0726765562.USD","LU2092627202.USD","MSDD","LU1670627923.USD","LU2360108059.USD","FINX","LU2355687059.USD","IE00B19Z9Z06.USD","LU0894486033.HKD","LU1582986359.USD","BK4595","LU1814569148.SGD","LU0354030438.USD","LU1046421795.USD","LU0138981039.USD","IBLC","LU1206712785.SGD","LU2125909759.SGD","BK7508","LU2506952170.USD","AAPE","SHOC","LU0757359954.USD","AVGU","LU2210150020.SGD","IE0034235295.USD","SAAPLmain","LU1162221912.USD","IE00BLSP4239.USD","MSTX","LU1791710400.SGD","IE00B894F039.SGD","LU0276348264.USD","LU1803068979.SGD","IE00B7SZLL34.SGD","IE00BMCWC346.EUR","LU0094547139.USD","LU2047632596.USD","LU1992135472.HKD","SNPE","WUGI","SG9999014914.USD","LU1196500208.SGD","LU0320765059.SGD","LU1066051225.USD","LU1291159041.SGD","SG9999018857.SGD","AMDS","LU0878866978.SGD","LU2125909593.SGD","LU2264538146.SGD","CGGO","07788","BK7096","SAVGOmain","LU1803068623.USD","SG9999014898.SGD","BK4505","SG9999015945.SGD","LU1670710588.SGD","LU1804176565.USD","LU2211814178.USD","IE00BZ1G4Q59.USD","LU0689626769.HKD","09711","BK4551","07311","AAPX","LU2023250330.USD","LU1043141396.HKD","IE0003U64NQ7.SGD","LU1582986433.USD","LU0426412945.USD","LU0823434583.USD","LU1861559042.SGD","IE00B775SV38.USD","IE0004445015.USD","LU0426417589.USD","NVDQ","SG9999017495.SGD","HK0000306685.HKD","NVDU","OGIG","BK4602","SG9999014906.USD","LU0310800379.SGD","BK4170","LU2491050154.USD","IE0004445239.USD","LU1571399168.USD","LU1551013425.SGD","SG9999015952.SGD","LU0203345920.USD","NVDO","LU0889566641.SGD","LU2028103732.USD","LU2602419157.SGD","LU0256863811.USD","LU1934455277.USD","LU1066051498.USD","09788","AMD.AU","LU2041044095.USD","LU1935043023.USD","JGRO","LU2237957811.SGD","BK4011","LU1074936037.SGD","LU1778281490.HKD","LU0157215616.USD","ORCU","TTEQ","LU1201861249.SGD","IE00BFXG1179.USD","AGOX","IE0001KFT4U8.USD","LU0879622024.SGD","MSTK","IE00B3PB1722.GBP","LU0171293334.USD","LU2381873111.SGD","LU1951200564.SGD","BK4534","FDTX","LU0274383776.USD","LU2362540622.SGD","LU2764262908.HKD","IE0002270589.USD","LU0096362180.USD","IE00BJJMRX11.SGD","IE00BVYPNW00.USD","LU1868836914.USD","LU1815333072.USD","NVDS","LU0545039389.USD","LU2236285917.USD","BK4112","IE0009356076.USD","LU2471134952.CNY","ROM","LU1267930490.SGD","NVDG","LU1721428933.USD","HK0000320264.USD","LU2054465674.USD","MSST","LU1366333091.USD","IMST","MSOO","LU2458330169.SGD","FCOM","MSTR.AU","LU1066051811.HKD","LU2065169927.USD","09399","LU2213496289.HKD","LU1496350502.SGD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667611515","title":"Australian Shares Fall; White Cliff Says Hancock Prospecting to Take 13.5% Stake With Nearly AU$9 Million Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2667611515","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667611515?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:23","pubTimestamp":1789453413,"startTime":"0","endTime":"0","summary":"Australian shares closed lower on Tuesday, tracking losses on Wall Street as the prospect of a rate hike in the US loomed.The S&P/ASX 200 Index fell by 0.88%, or 77.40 points, to close at 8,672.50, re","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HBHC","BEAR.AU","IOZ.AU","VAS.AU","GEAR.AU","IMLC.AU","BK7095","BK7096","OZF.AU","XJO.AU","QFN.AU","XAO.AU","EIGA.AU","STW.AU","WCN.AU","BK7508","GIVE.AU","MYX.AU","E200.AU","IISV.AU","DACE.AU","VAP.AU","ZYAU.AU","OZR.AU","XKO.AU","BBOZ.AU","NIC.AU","IIGF.AU","QRE.AU","SLF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667616451","title":"Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667616451","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667616451?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:33","pubTimestamp":1789450429,"startTime":"0","endTime":"0","summary":"Immutep's  eftilagimod alfa drug candidate, or efti, now has a clearer potential development path after the early termination of the TACTI-004 study, according to a Tuesday note by Jefferies.Its root cause analysis increasingly supports TACTI-004 as a potentially isolated product-specific structural issue rather than a failure of efti's biology. The identification of subtle N-glycan differences in the efti material used in TACTI-004 is potentially important.With prior efti data intact, head and neck squamous cell carcinoma prioritization, fast-track status, and planned manufacturing work, the risk and reward look more constructive despite residual execution risk.The brokerage upgraded its rating on Immutep to buy from hold with the price target rising to AU$0.08 per share from AU$0.04.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","IMM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667692474","title":"Immutep Gets a New Bull at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2667692474","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667692474?lang=en_us&edition=fundamental","pubTime":"2026-09-15 09:09","pubTimestamp":1789434540,"startTime":"0","endTime":"0","summary":"0109 GMT - Immutep gets a new bull at Jefferies, where analyst David Stanton sees a clearer potential development path for the biotechnology company's lead product candidate. Raising his recommendation to buy from hold, Stanton is encouraged by the Australian company's update that the early discontinuation of a lung cancer study doesn't appear to be linked to clinical factors or trial execution. Emerging evidence supports a cautiously constructive view that the outcome stemmed from an isolated manufacturing or product-characterisation issue, Stanton explains in a note to clients. Risk/reward looks more constructive to Stanton, who now includes Immutep's phase IIhead and neck squamous cell carcinoma opportunity in his valuation. Jefferies doubles its target price to 8 Australian cents. Shares are flat at 4.7 Australian cents.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMM.AU","BK7067","BK7508","IMMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667947016","title":"Paradigm Biopharmaceuticals Names Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667947016","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667947016?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:39","pubTimestamp":1789432751,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals  appointed Daniel Furtner as its Chief Medical Officer, effective Wednesday, according to a Tuesday Australian bourse filing.Furtner succeeds Donna Skerrett, who will remain with the firm as a senior scientific advisor.Furtner previously served as the senior director of medical affairs for the Asia Pacific region at CSL.Its shares fell 2% in recent trading on Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","PAR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667250694","title":"Mayne Pharma Signs Five-Year Exclusive Deal With Italfarmaco","url":"https://stock-news.laohu8.com/highlight/detail?id=2667250694","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667250694?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:32","pubTimestamp":1789432343,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  has entered into an exclusive five-year agreement with Italfarmaco to register, market and distribute Blissel, an ultra-low-dose vaginal gel for menopause-related vaginal atrophy, in Australia, according to a Tuesday Australian bourse filing.Blissel is targeted for launch in fiscal 2028 through the company's existing women's health commercial team, expanding its menopause portfolio alongside NEXTSTELLIS, per the filing.Australia's topical vaginal estrogen market is worth around AU$27 million in 2025, growing at a 16% two-year compound annual growth rate, with the company expecting Blissel to contribute to international sales, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","MYX.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691491","title":"Mayne Pharma Group Ltd-Myx Signs Licence Agreement for Blissel in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691491?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:51","pubTimestamp":1789429863,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3VY8ZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667496691","title":"Mayne Pharma Group - Signs Exclusive Five-Year Licence Agreement with Italfarmaco S.a for Blissel in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2667496691","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667496691?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:51","pubTimestamp":1789429863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3VY8ZX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667911446","title":"Paradigm Biopharmaceuticals Ltd-DR Daniel Furtner Appointed Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667911446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667911446?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:47","pubTimestamp":1789429621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE69ZBXD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","PAR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667569924","title":"Prescient Therapeutics Ltd-Prescient Therapeutics - Extension of Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2667569924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667569924?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:00","pubTimestamp":1789426817,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUEBBQWSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PTX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667632159","title":"Australia's Dimerix Rises on Patent Approval in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2667632159","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667632159?lang=en_us&edition=fundamental","pubTime":"2026-09-14 11:59","pubTimestamp":1789358350,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix rises on patent approval in Mexico** Shares of Australia's DimerixDXB.AXrise as much as 10% to A$0.275, marking their biggest pct gain since August 20** Clinical-stage biopharmaceutical company says Mexico has granted a patent for DMX-652, a drug candidate for acute kidney injury** The patent expands protection for DMX-652 in Mexico, one of Latin America's largest pharmaceutical markets** Co says the approval strengthens the commercial potential of DMX-652, following a similar approval for the drug in U.S.** YTD down 53.6%, including the session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N45604Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667563433","title":"ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2667563433","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667563433?lang=en_us&edition=fundamental","pubTime":"2026-09-14 10:38","pubTimestamp":1789353499,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced 1% at midday Monday.CSL (ASX:CSL) gained nearly 2% in recent trade.On the flip side, the materials sector struggled, shedding nearly 1%.BHP Group (ASX:BHP) shares fell past 1% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","CSL.AU","BK7508","BK4581","XLV","HCSG","LU0128526141.USD","BHP.AU","BK7095","BK4585","BK7511","BK4137","LU0029874061.USD","LABU","BK7501","UYM","XBI","BK7067","BK7507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636149","title":"Biotron - Michelle Miller Steps Down as Managing Director and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636149","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636149?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:36","pubTimestamp":1789346171,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3HYPDN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIT.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636146","title":"Biotron - Board Commences Search for New Leadership Effective Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636146","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636146?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:36","pubTimestamp":1789346171,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3HYPDN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","BIT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667563614","title":"Biotron Ltd-Resignation of Managing Director and Appendix 3Z","url":"https://stock-news.laohu8.com/highlight/detail?id=2667563614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667563614?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:36","pubTimestamp":1789346171,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3HYPDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BIT.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636275","title":"CitiFirst CSL Instalments Dividend Final Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636275","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636275?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:32","pubTimestamp":1789345953,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260914:nASX9H7YgV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nASXcdLQt8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7067","BK7508","BK7501","BK7511"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}]}}